Cefepime Hydrochloride

Generic Name: cefepime hydrochloride

Over-the-Counter (OTC)

Brand Names:

11 DESCRIPTION Cefepime for Injection, USP (cefepime hydrochloride, USP) is a semi-synthetic, cephalosporin antibacterial for parenteral administration. The chemical name is 1-[[(6R,7R)-7-[2-(2-amino-4-thiazolyl)-glyoxylamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-en-3-yl]methyl]-1-methylpyrrolidinium chloride,72-(Z)-(O-methyloxime), monohydrochloride, monohydrate, which corresponds to the following structural formula: Structural formula Cefepime hydrochloride is a white to pale yello...

Overview

Uses

1 INDICATIONS AND USAGE Cefepime for injection is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms: Pneumonia. ( 1.1 ) Empiric therapy for febrile neutropenic patients. ( 1.2 ) Uncomplicated and complicated urinary tract infections (including pyelonephritis). ( 1.3 ) Uncomplicated skin and skin structure infections. ( 1.4 ) Complicated intra-abdominal infections (used in combination with metronidazole) in adults.

Dosage

2 DOSAGE AND ADMINISTRATION Recommended Dosage in Adults with Creatinine Clearance (CrCL) Greater Than 60 mL/min ( 2.1 ) Site and Type of Infection Dose Frequency Duration (days) Moderate to Severe Pneumonia § 1 to 2 g IV Every 8 to 12 hours 10 Empiric Therapy for Febrile Neutropenic Patients 2 g IV Every 8 hours 7* Mild to Moderate Uncomplicated or Complicated Urinary Tract Infections 0.5 to 1 g IV/IM** Every 12 hours 7 to 10 Severe Uncomplicated or Complicated Urinary Tract Infections 2 g IV Every 12 hours 10 Moderate to Severe Uncomplicated Skin and Skin Structure Infections 2 g IV Every 12 hours 10 Complicated Intra-abdominal Infections § (used in combination with metronidazole) 2 g IV Every 12 hours 7 to 10 § For Pseudomonas aeruginosa , use 2 g IV every 8 hours.

Side Effects

6 ADVERSE REACTIONS The following adverse reactions are discussed in the Warnings and Precautions section and below: Hypersensitivity Reactions [ see Warnings and Precautions ( 5.1 ) ] Neurotoxicity [ see Warnings and Precautions ( 5.2) ] Clostridioides difficile -Associated Diarrhea [ see Warnings and Precautions (5.3 ) ] The most common adverse reactions (incidence ≥ 1%) were local reactions, positive Coombs' test, decreased phosphorous, increased ALT and AST, increased PT and PTT and rash. ( 6.1 ) At the highest dose (2 g every 8 hours), incidence of adverse reactions was ≥1% for rash, diarrhea, nausea, vomiting, pruritis, fever, and headache. (6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc.

Interactions

7 DRUG INTERACTIONS Aminoglycosides: increased potential of nephrotoxicity and ototoxicity. Monitor renal function. ( 7.2 ) Diuretics: nephrotoxicity has been reported following concomitant administration of other cephalosporins with potent diuretics such as furosemide. Monitor renal function. ( 7.3 ) 7.1 Drug/Laboratory Test Interactions The administration of cefepime may result in a false-positive reaction for glucose in the urine with certain methods. It is recommended that glucose tests based on enzymatic glucose oxidase reactions be used. 7.2 Aminoglycosides Monitor renal function if aminoglycosides are to be administered with cefepime for injection because of the increased potential of nephrotoxicity and ototoxicity of aminoglycoside antibacterial drugs.

Warnings

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Cross-hypersensitivity among beta-lactam antibacterial drugs may occur in up to 10% of patients with a history of penicillin allergy. If an allergic reaction to Cefepime for Injection occurs, discontinue the drug. ( 5.1 ) Neurotoxicity: May occur especially in patients with renal impairment administered unadjusted doses. If neurotoxicity associated with cefepime for injection therapy occurs, discontinue the drug. ( 5.2 ) Clostridioides difficile Associated Diarrhea (CDAD): Evaluate if diarrhea occurs. 4 CONTRAINDICATIONS Cefepime for injection is contraindicated in patients who have shown immediate hypersensitivity reactions to cefepime or the cephalosporin class of antibacterial drugs, penicillins or other beta-lactam antibacterial drugs. Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. ( 4 )

Pregnancy

8.1 Pregnancy Risk Summary There are no cases of cefepime for injection exposure during pregnancy reported from postmarketing experience or from clinical trials. Available data from published observational studies and case reports over several decades with cephalosporin use in pregnant women have not established drug-associated risks of major birth defects, miscarriage or adverse maternal or fetal outcomes ( see Data ). Cefepime was not associated with adverse developmental outcomes in rats, mice, or rabbits when administered parenterally during organogenesis.

Storage

16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied Cefepime for injection is supplied as follows: Cefepime for Injection, USP in the dry state, is a white to pale yellow powder. Constituted solution of Cefepime for Injection, USP can range in color from pale yellow to amber.

Frequently Asked Questions

What is Cefepime Hydrochloride used for?▼

What are the side effects of Cefepime Hydrochloride?▼

Can I take Cefepime Hydrochloride during pregnancy?▼

What are the important warnings for Cefepime Hydrochloride?▼

Related Medications

Vitamin A Acetate, Ascorbic Acid, Cholecalciferol, Alpha-tocopherol Acetate, Dl, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Biotin, Calcium Pantothenate, Calcium Carbonate, Ferrous Fumarate, Potassium Iodide, Magnesium Oxide, Zinc Oxide And Cupric Oxide

vitamin a acetate, ascorbic acid, cholecalciferol, alpha-tocopherol acetate, dl, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, biotin, calcium pantothenate, calcium carbonate, ferrous fumarate, potassium iodide, magnesium oxide, zinc oxide and cupric oxide

Vitamin C [EPC]

DESCRIPTION: PNV-Select is a prescription prenatal dietary supplement tablet that contains multivitamins and minerals, which are delivered in the form of a white, oval, oil-and water-soluble, film-coated tablet debossed with “320” on one side. table OTHER INGREDIENTS: Dicalcium Phosphate, Cellulose, Croscarmellose Sodium, Stearic Acid, Silicon Dioxide, Magnesium Stearate, Film Coating (Hydroxy Propyl Methyl Cellulose, Triacetin, Titanium Dioxide).

Feliscatushair,bostaurushair,bostaurusskin,gallusgallusfeather,canislupusfamiliarisskin,canisfamiliarishair,anasplatyrhynchosfeather,anseranserfeather,caviaporcellushair,caviaporcellusskin,mesocricetusauratushair,mesocricetusauratusskin,susscrofahair,susscrofaskin,equuscaballushair,equuscaballusdander,musmusculushair,musmusculuasskin,oryctolaguscuniculusskin,oryctolaguscuniculushair,ovisarieswhole,meleagrisgallopavofeather,arsenictrioxide,blattaorientalis,strychnosnux-vomicaseed,phosphorus,pulsatilla,sulfur

feliscatushair,bostaurushair,bostaurusskin,gallusgallusfeather,canislupusfamiliarisskin,canisfamiliarishair,anasplatyrhynchosfeather,anseranserfeather,caviaporcellushair,caviaporcellusskin,mesocricetusauratushair,mesocricetusauratusskin,susscrofahair,susscrofaskin,equuscaballushair,equuscaballusdander,musmusculushair,musmusculuasskin,oryctolaguscuniculusskin,oryctolaguscuniculushair,ovisarieswhole,meleagrisgallopavofeather,arsenictrioxide,blattaorientalis,strychnosnux-vomicaseed,phosphorus,pulsatilla,sulfur

Non-Standardized Feather Allergenic Extract [EPC]

Uses : Temporarily relieves symptoms associated with allergic responses to animals.**

Acetaminophen, Dextromethorphan Hbr, Doxylamine Succinate, Guaifenesin, Phenylephrine Hcl

acetaminophen, dextromethorphan hbr, doxylamine succinate, guaifenesin, phenylephrine hcl

Purpose Pain reliever/fever reducer Cough suppressant Expectorant Nasal decongestant

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.